Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/01/2026 ,inter alia, to consider and approve proposals for raising ....
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on January 7, 2026. The main item on the agenda is to consider and evaluate raising funds by issuing convertible warrants on a preferential basis to the promoters and promoter group. The Board will also decide the issue price for these warrants. The proposal will follow the Companies Act, 2013 and SEBI ICDR Regulations, and will require approvals from the Board, shareholders, and regulators. The trading window for insiders is already closed since January 1, 2026 due to the upcoming quarterly results.
Issuing convertible warrants to promoters signals promoter confidence and a potential capital infusion, but it also means dilution for existing public shareholders once the warrants are exercised. The stock may see short-term volatility around the board meeting on January 7.